INVEX Therapeutics Ltd (IXC) — Cash Flow Quality Index

Latest as of June 2024: -0.27x

INVEX Therapeutics Ltd (IXC) has a Cash Flow Quality Index of -0.27x as of June 2024. Operating cash flow of AU$-126.75K is below net income of AU$470.89K, suggesting accrual-heavy earnings not yet converted to cash. Explore INVEX Therapeutics Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.27x

Operating CF / Net Income

Operating Cash Flow

AU$-126.75K

AUD

Net Income

AU$470.89K

AUD

Data as of

Jun 2024

Most recent filing

Annual Cash Flow Quality Index for INVEX Therapeutics Ltd (None–None)

Year-by-year earnings quality comparison for INVEX Therapeutics Ltd.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.